Brind.

Morgan Stanley raised its price objective for Ionis Pharmaceuticals stock, which trades on the Nasdaq exchange.

1 report, 1 independent Updated Jul 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Ionis Pharmaceuticals Morgan Stanley

Keep exploring

The entities involved

Ionis Pharmaceuticals
American pharmaceutical company
- GSK and Ionis Pharmaceuticals co-developed the bepirovirsen drug for hepatitis B.Sat 18:16
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

Morgan Stanley was involved in market activity on the electronic stock exchange, with filings received regarding this activity.Sep 9
Morgan Stanley raised the price objective for Estee Lauder Companies Inc. on September 10th.Sep 10
Morgan Stanley analysts hiked price targets for Salesforce.Aug 27
Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.Sep 15
Daiwa Securities Group raised its price objective on Morgan Stanley, and Citigroup boosted its target price on Morgan Stanley stock.Aug 30

Coverage

Newest first; wire copies grouped

Jul 1themarketsdaily.com